Author

Carla Della Ventura

University of MilanORCID 0009-0005-0055-1827Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Ada MescoliiD· 1 shared Alessia LaiiD· 1 shared Alice ProsperiiD· 1 shared Ambra Nucci· 1 shared Ana MorenoiD· 1 shared Andrea TrabocchiiD· 1 shared Annalisa BergnaiD· 1 shared Arianna GabrieliiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Ada MescoliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyJournal of General VirologyPeer-reviewedNov 13, 2025

From North to South: Transmission Dynamics of H1N1pdm09 Swine Influenza A Viruses in Italy

Marta Giovanetti, Eleonora Cella, Laura Soliani…·Ana Moreno

This study analyzes the genetic diversity and transmission dynamics of H1N1pdm09 swine influenza viruses in Italy using whole genome sequencing and dynamic modeling, revealing multiple introductions and limited onward transmission with some sustained clusters.

1 citation

whole-genome sequencingstatistical model

𝕏 PostBluesky

MicrobiologybioRxivPreprintOct 30, 2025

In vitro Characterization of Peptidomimetic Proteolysis Targeting Chimera (PROTAC) as a Degrader of 3-Chymotrypsin-Like Protease (Mpro/3CLpro) against SARS-CoV-2

Mirko Giuseppe Liturri, Annalisa Bergna, Alessia Lai…·Stefano Rusconi

The paper characterizes FT235, a PROTAC degrader of SARS-CoV-2 3CLpro, showing antiviral activity and reduced cytotoxicity.

DOI 10.1101/2025.10.30.685646

experimental assaydrug response / drug discovery

𝕏 PostBluesky